BMO Capital Markets restated their outperform rating on shares of Cooper Companies (NYSE:COO) in a report issued on Friday. BMO Capital Markets currently has a $280.00 price objective on the medical device company’s stock, up from their prior price objective of $277.00.
Several other research analysts have also weighed in on the company. Stifel Nicolaus reiterated a buy rating and set a $265.00 target price (down from $275.00) on shares of Cooper Companies in a report on Friday, December 8th. Oppenheimer set a $250.00 target price on Cooper Companies and gave the stock a hold rating in a report on Friday, December 8th. Zacks Investment Research lowered Cooper Companies from a buy rating to a hold rating in a report on Monday, January 8th. Raymond James Financial reiterated a buy rating and set a $265.00 target price on shares of Cooper Companies in a report on Monday, December 4th. Finally, Cleveland Research lowered Cooper Companies from a buy rating to a hold rating in a report on Friday, February 9th. Eight analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company currently has an average rating of Hold and an average price target of $267.50.
Cooper Companies (NYSE COO) opened at $251.43 on Friday. Cooper Companies has a 12-month low of $192.24 and a 12-month high of $260.26. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.83 and a quick ratio of 1.61. The stock has a market capitalization of $12,325.45, a price-to-earnings ratio of 23.76, a PEG ratio of 1.98 and a beta of 0.61.
In other Cooper Companies news, Director A Thomas Bender sold 9,150 shares of Cooper Companies stock in a transaction dated Monday, December 18th. The stock was sold at an average price of $229.17, for a total value of $2,096,905.50. Following the sale, the director now owns 11,205 shares of the company’s stock, valued at approximately $2,567,849.85. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stanley Md Zinberg sold 5,000 shares of Cooper Companies stock in a transaction dated Thursday, January 4th. The shares were sold at an average price of $224.66, for a total value of $1,123,300.00. Following the completion of the sale, the director now directly owns 6,090 shares in the company, valued at approximately $1,368,179.40. The disclosure for this sale can be found here. Insiders sold a total of 54,385 shares of company stock worth $12,289,463 in the last three months. Company insiders own 1.60% of the company’s stock.
Several institutional investors and hedge funds have recently added to or reduced their stakes in COO. BB&T Investment Services Inc. increased its position in shares of Cooper Companies by 71.0% in the fourth quarter. BB&T Investment Services Inc. now owns 542 shares of the medical device company’s stock valued at $119,000 after acquiring an additional 225 shares during the last quarter. Canada Pension Plan Investment Board acquired a new stake in shares of Cooper Companies in the third quarter valued at about $163,000. Virtue Capital Management LLC acquired a new stake in shares of Cooper Companies in the fourth quarter valued at about $195,000. FNY Managed Accounts LLC acquired a new stake in shares of Cooper Companies in the fourth quarter valued at about $217,000. Finally, CAPROCK Group Inc. acquired a new stake in shares of Cooper Companies in the fourth quarter valued at about $222,000. 98.55% of the stock is currently owned by hedge funds and other institutional investors.
About Cooper Companies
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.